Test Drive Our New Site! We have some improvements in the works that we're excited for you to experience. Click here to try our new, faster, mobile friendly beta site. We will be maintaining our current version of the site thru the end of 2024, so you can switch back as our improvements continue.
Legislation Quick Search
05/29/2024 10:27 AM
Pennsylvania House of Representatives
https://www.legis.state.pa.us/cfdocs/Legis/CSM/showMemoPublic.cfm?chamber=H&SPick=20230&cosponId=41339
Share:
Home / House Co-Sponsorship Memoranda

House Co-Sponsorship Memoranda

Subscribe to PaLegis Notifications
NEW!

Subscribe to receive notifications of new Co-Sponsorship Memos circulated

By Member | By Date | Keyword Search


House of Representatives
Session of 2023 - 2024 Regular Session

MEMORANDUM

Posted: August 29, 2023 12:39 PM
From: Representative Danielle Friel Otten
To: All House members
Subject: Insurance Coverage of Obesity Treatments
 
Millions of Americans battle obesity every day, with many affected individuals struggling to manage their weight through increased dieting and exercise. More often than not, these efforts have limited success. Obesity is not a lifestyle choice, but rather a chronic disease that in many cases requires medical treatment and support.

Modern advances in the field of obesity medicine have provided hope and healthier lives for countless Americans, but insurance coverage for anti-obesity medications (AOMs) and other approved obesity treatments remains inconsistent, leaving many Pennsylvanians to fight obesity on their own, or worse, fall victim to predatory scams and the use of unregulated, ineffective, and sometimes dangerous products that claim to provide the same benefits as prescribed and clinically tested AOMs.

For these reasons, I am introducing legislation to require private and public insurance plans in Pennsylvania to cover approved anti-obesity medications and procedures.

Please join me in this effort to ensure coverage for obesity treatments and improve the treatment options available to individuals with obesity. This legislation would protect patient safety by ensuring access to regulated treatments and relieve the strain on our healthcare system by helping to reduce the prevalence of obesity-related health conditions such as heart disease, stroke, hypertension, and Type 2 diabetes. Most importantly, expanding coverage under public and private health insurance plans would help individuals with obesity access the treatments they need to live longer, healthier lives.